(Total Views: 79)
Posted On: 10/16/2023 2:40:56 PM
Post# of 36044
$IRWD News Article - Ironwood Pharmaceuticals Presents Positive Final Data from STARS Nutrition, a Phase II Study of Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) and Colon in Continuity (CIC) at United European Gastroenterology Week https://marketwirenews.com/news-releases/iron...01148.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
